In a prospective single-center series of 88 eyes, the Clareon monofocal IOL produced good distance vision and predictable refraction, but follow-up was too short to assess late glistenings.
In a prospective series of 115 eyes, typical angle-kappa and angle-alpha values showed no clinically important association with outcomes of a nondiffractive EDOF IOL at three months.
A randomized trial in 66 patients found lower pressure and a lower medication burden at two years after phacoemulsification with ECP than after phacoemulsification alone.
In a retrospective series of 158 eyes, retreatment improved vision and refraction, but LASIK, PRK and ICL groups differed greatly in size and were selected by clinical indication.
In a multicenter retrospective cohort of 919 patients, SMILE was associated with less residual myopia and greater refractive stability, but procedure selection was not randomized.
In an early nonrandomized series, ray-tracing LASIK more often achieved 20/20 and left less cylinder than SMILE Pro, but the comparison reflects one surgeon's initial experience.
In a post-hoc analysis of 226 eyes, Barrett Universal II and Kane produced lower absolute error after secondary sutureless intrascleral fixation of a one-piece IOL.
In a retrospective series of 64 eyes, horizontal and vertical flanged intrascleral fixation produced comparable six-month visual and refractive outcomes.
In a 160-eye real-world series, the toric Eyhance corrected astigmatism and provided useful distance and intermediate vision, but 79% of assessed patients used reading glasses.
A meta-analysis of 12 comparative studies found that toric IOLs reduced residual cylinder and improved uncorrected distance vision in cataract patients with pre-existing corneal astigmatism.